NO20034667L - Arylsulfonamider som antivirale midler - Google Patents

Arylsulfonamider som antivirale midler

Info

Publication number
NO20034667L
NO20034667L NO20034667A NO20034667A NO20034667L NO 20034667 L NO20034667 L NO 20034667L NO 20034667 A NO20034667 A NO 20034667A NO 20034667 A NO20034667 A NO 20034667A NO 20034667 L NO20034667 L NO 20034667L
Authority
NO
Norway
Prior art keywords
sup
arylsulfonamides
antivirals
substituents
processes
Prior art date
Application number
NO20034667A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034667D0 (no
Inventor
Tobias Wunberg
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Joerg Keldenich
Armin Kern
Siegfried Raddatz
Juergen Reefschlaeger
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20034667D0 publication Critical patent/NO20034667D0/no
Publication of NO20034667L publication Critical patent/NO20034667L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20034667A 2001-04-19 2003-10-17 Arylsulfonamider som antivirale midler NO20034667L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (2)

Publication Number Publication Date
NO20034667D0 NO20034667D0 (no) 2003-10-17
NO20034667L true NO20034667L (no) 2003-12-12

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034667A NO20034667L (no) 2001-04-19 2003-10-17 Arylsulfonamider som antivirale midler

Country Status (20)

Country Link
US (1) US7115612B2 (https=)
EP (1) EP1383749B1 (https=)
JP (1) JP4480941B2 (https=)
CN (1) CN1516695A (https=)
AT (1) ATE308529T1 (https=)
BG (1) BG108272A (https=)
BR (1) BR0209054A (https=)
CA (1) CA2444123C (https=)
DE (1) DE50204780D1 (https=)
EE (1) EE200300515A (https=)
ES (1) ES2252455T3 (https=)
HU (1) HUP0303813A3 (https=)
IL (1) IL158324A0 (https=)
MX (1) MXPA03009548A (https=)
NO (1) NO20034667L (https=)
PL (1) PL363990A1 (https=)
RU (1) RU2003133750A (https=)
SK (1) SK12662003A3 (https=)
UY (1) UY27263A1 (https=)
WO (1) WO2002085869A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050168A2 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
HUE047569T2 (hu) 2003-04-11 2020-04-28 Ptc Therapeutics Inc 1,2,4-oxadiazol-benzoesav vegyület és nonszensz szupresszióra történõ alkalmazása
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
RU2462246C2 (ru) 2006-03-30 2012-09-27 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы получения функционального белка из днк, имеющей нонсенс-мутацию, и лечения нарушений, ассоциированных с ней
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
CA2692379A1 (en) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Antiproliferative compounds based on 5-membered heterocycles
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
CA2803695A1 (en) * 2010-06-28 2012-01-05 Bayer Intellectual Property Gmbh Heteroaryl-substituted pyridine compounds for use as pesticides
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
JP6372666B2 (ja) 2012-11-03 2018-08-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害剤
WO2014070978A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
EP2935257B1 (en) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
KR102497273B1 (ko) 2014-03-06 2023-02-07 피티씨 테라퓨틱스, 인크. 1,2,4-옥사디아졸 벤조산의 약학 조성물 및 염
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3256461B1 (en) * 2015-02-13 2023-09-13 Azienda Ospedaliera Universitaria Senese Urea and sulfonamide derivatives as human helicase ddx3 inhibitors useful in the treatment of viral diseases
JP2018531975A (ja) 2015-10-30 2018-11-01 ピーティーシー セラピューティクス，インコーポレーテッド てんかんの治療方法
CN120136858A (zh) * 2017-03-31 2025-06-13 中美博瑞纳制药有限公司 可用作alcat1抑制剂的化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
AU765203B2 (en) 1999-04-19 2003-09-11 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
EP1383749A1 (de) 2004-01-28
ATE308529T1 (de) 2005-11-15
CA2444123C (en) 2010-09-21
CN1516695A (zh) 2004-07-28
DE50204780D1 (de) 2005-12-08
HUP0303813A2 (hu) 2004-03-29
NO20034667D0 (no) 2003-10-17
JP2004531536A (ja) 2004-10-14
CA2444123A1 (en) 2002-10-31
US20040176374A1 (en) 2004-09-09
MXPA03009548A (es) 2004-05-24
HUP0303813A3 (en) 2005-05-30
BG108272A (bg) 2004-10-29
WO2002085869A1 (de) 2002-10-31
EE200300515A (et) 2004-02-16
BR0209054A (pt) 2004-04-20
JP4480941B2 (ja) 2010-06-16
SK12662003A3 (sk) 2004-04-06
IL158324A0 (en) 2004-05-12
US7115612B2 (en) 2006-10-03
ES2252455T3 (es) 2006-05-16
EP1383749B1 (de) 2005-11-02
UY27263A1 (es) 2002-11-29
PL363990A1 (en) 2004-11-29
RU2003133750A (ru) 2005-05-10

Similar Documents

Publication Publication Date Title
NO20034667D0 (no) Arylsulfonamider som antivirale midler
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
BR0114045A (pt) Poliarilcarboxamidas úteis como agentes redutores de lipìdeos
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
GT200000103A (es) Trifluorbutenos nematocidas.
DE60212949D1 (de) Antivirale pyrazolopyridin verbindungen
ATE365740T1 (de) Substituierte pyrazolopyrimidine
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
MXPA02011370A (es) Iminoazinas substituidas.
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ATE300541T1 (de) Pyrazolopyridinderivate
NO20054787L (no) Indenderivater som farmasotiske midler
ATE297903T1 (de) Substituierte phenyluracile
SE0101038D0 (sv) Novel compounds
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
DK1204659T3 (da) Serotonerge benzofuraner
DE60201074D1 (en) Pyrazolopyridinderivate
HRP20010798B1 (hr) Postupci priprave pesticidnih međuprodukata
SE9904128D0 (sv) Novel compounds
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application